These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 10375998

  • 1. [Thromboxane A2 antagonist--discovery of seratrodast].
    Terao S, Shiraishi M, Matsumoto T, Ashida Y.
    Yakugaku Zasshi; 1999 May; 119(5):377-90. PubMed ID: 10375998
    [Abstract] [Full Text] [Related]

  • 2. [Correlation between the clinical effects of Seratrodast and the level of 11-dehydrothromboxane B2 in urine/sputum in bronchial asthma patients].
    Muramatsu H, Kotajima R, Sato T.
    Arerugi; 2001 Jun; 50(6):540-6. PubMed ID: 11517517
    [Abstract] [Full Text] [Related]

  • 3. The effect of seratrodast on eosinophil cationic protein and symptoms in asthmatics.
    Fukuoka T, Miyake S, Umino T, Inase N, Tojo N, Yoshizawa Y.
    J Asthma; 2003 May; 40(3):257-64. PubMed ID: 12807169
    [Abstract] [Full Text] [Related]

  • 4. Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics.
    Aizawa H, Inoue H, Nakano H, Matsumoto K, Yoshida M, Fukuyama S, Koto H, Hara N.
    Prostaglandins Leukot Essent Fatty Acids; 1998 Sep; 59(3):185-90. PubMed ID: 9844991
    [Abstract] [Full Text] [Related]

  • 5. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs.
    Ishimura M, Suda M, Morizumi K, Kataoka S, Maeda T, Kurokawa S, Hiyama Y.
    Br J Pharmacol; 2008 Feb; 153(4):669-75. PubMed ID: 18037905
    [Abstract] [Full Text] [Related]

  • 6. Effect of YM158, a dual lipid mediator antagonist, on immediate and late asthmatic responses, and on airway hyper-responsiveness in guinea pigs.
    Arakida Y, Ohga K, Suwa K, Okada Y, Morio H, Yokota M, Miyata K, Yamada T, Honda K.
    Jpn J Pharmacol; 2000 Apr; 82(4):287-94. PubMed ID: 10875747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis.
    Yamasaki M, Mizutani N, Sasaki K, Nabe T, Matsumoto T, Ashida Y, Kohno S.
    Inflamm Res; 2001 Sep; 50(9):466-73. PubMed ID: 11603852
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thromboxane A2 inhibition: therapeutic potential in bronchial asthma.
    Dogné JM, de Leval X, Benoit P, Delarge J, Masereel B.
    Am J Respir Med; 2002 Sep; 1(1):11-7. PubMed ID: 14720071
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Repeated antigen inhalations alter chemical mediators that cause asthmatic obstruction in guinea pigs.
    Yamashita K, Nabe T, Tomioka H, Kohno S.
    Jpn J Pharmacol; 1999 Sep; 81(1):48-55. PubMed ID: 10580370
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Thromboxane A2 synthase inhibitor and receptor antagonist].
    Minoguchi K, Adachi M.
    Nihon Rinsho; 2001 Oct; 59(10):1986-91. PubMed ID: 11676143
    [Abstract] [Full Text] [Related]

  • 19. Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients?
    Tanaka H, Igarashi T, Saitoh T, Teramoto S, Miyazaki N, Kaneko S, Ohmichi M, Abe S.
    Respir Med; 1999 Dec; 93(12):891-7. PubMed ID: 10653051
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.